Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models

Ranson, 1974, Prognostic signs and role of operative management in acute pancreatitis, Surg Gynecol Obstet, 139, 69 Ranson, 1976, Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis, Surg Gynecol Obstet, 143, 209 Ranson, 1982, Etiological and prognostic factors in human acute pancreatitis: A review, Am J Gastroenterol, 77, 633 Imrie, 1978, A single centre double blind trial of Trasylol therapy in primary acute pancreatitis, Br J Surg, 65, 337, 10.1002/bjs.1800650514 Blamey, 1984, Prognostic factors in acute pancreatitis, Gut, 25, 1340, 10.1136/gut.25.12.1340 Knaus, 1985, A severity of disease classification system, Crit Care Med, 13, 818, 10.1097/00003246-198510000-00009 Halonen, 2000, Severe acute pancreatitis-prognostic factors in 270 consecutive patients, Pancreas, 21, 266, 10.1097/00006676-200010000-00008 Haybittle, 1982, A prognostic index in primary breast cancer, Br J Cancer, 45, 361, 10.1038/bjc.1982.62 Schuchter, 1996, A prognostic model for predicting 10-year survival in patients with primary melanoma, Ann Intern Med, 125, 369, 10.7326/0003-4819-125-5-199609010-00003 Lundin, 1999, Artificial neural networks applied to survival prediction in breast cancer, Oncology, 57, 281, 10.1159/000012061 Dubowski, 1996, Prediction of outcome in critically ill patients using artificial neural network synthesised by genetic algorithm, Lancet, 347, 1146, 10.1016/S0140-6736(96)90609-1 Golub, 1998, The prediction of common bile duct stones using a neural network, J Am Coll Surg, 187, 584, 10.1016/S1072-7515(98)00241-5 Burke, 1996, Statistical analysis of complex systems in biomedicine, vol 112, 251 Marshall, 1995, Multiple organ dysfuntion score: A reliable descriptor of a complex clinical outcome, Crit Care Med, 23, 1638, 10.1097/00003246-199510000-00007 Balthazar, 1985, Acute pancreatitis: Prognostic value of CT, Radiology, 156, 767, 10.1148/radiology.156.3.4023241 Balthazar, 1994, Imaging and intervention in acute pancreatitis, Radiology, 193, 297, 10.1148/radiology.193.2.7972730 Puolakkainen, 1987, C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis, Gut, 28, 764, 10.1136/gut.28.6.764 Büchler, 1986, Sensitivity of antiproteases, complement factors, and C-reactive protein in detecting pancreatic necrosis: Results of a prospective clinical study, Int J Pancreatol, 1, 227, 10.1007/BF02795248 Wilson, 1989, C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis, Br J Surg, 76, 177, 10.1002/bjs.1800760224 Wilson, 1990, Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems, Br J Surg, 77, 1260, 10.1002/bjs.1800771120 Metz, 1978, Basic principles of ROC analysis, Semin Nucl Med, 8, 283, 10.1016/S0001-2998(78)80014-2 Corfield, 1985, Prediction of severity in acute pancreatitis: Prospective comparison of three prognostic indices, Lancet, ii, 403, 10.1016/S0140-6736(85)92733-3 De Bernardinis, 1999, Discriminant power and information content of Ranson's prognostic signs in acute pancreatitis: A meta-analytic study, Crit Care Med, 27, 2272, 10.1097/00003246-199910000-00035 Eachempati, 2002, Severity scoring for prognostication in patients with severe acute pancreatitis: Comparative analysis of the Ranson score and the APACHE III score, Arch Surg, 137, 730, 10.1001/archsurg.137.6.730 Baxt, 1994, Complexity, chaos and human physiology: The justification for non-linear neural computational analysis, Cancer Lett, 77, 85, 10.1016/0304-3835(94)90090-6 Pofahl, 1998, Use of artificial neural network to predict length of stay in acute pancreatitis, Am Surg, 64, 868 Ranson, 1977, Statistical methods for quantifying the severity of clinical acute pancreatitis, J Surg Res, 22, 79, 10.1016/0022-4804(77)90045-2 Williamson, 1984, Early assessment of severity in acute pancreatitis, Gut, 25, 1331, 10.1136/gut.25.12.1331 Fan, 1988, Influence of age on mortality from acute pancreatitis, Br J Surg, 75, 463, 10.1002/bjs.1800750520 Lankisch, 1996, Etiology and age have only a limited influence on the course of acute pancreatitis, Pancreas, 13, 344, 10.1097/00006676-199611000-00003 Tenner, 1997, Relationship of necrosis to organ failure in severe acute pancreatitis, Gastroenterology, 113, 899, 10.1016/S0016-5085(97)70185-9 De Beux, 1995, Factors influencing morbidity and mortality in acute pancreatitis: An analysis of 279 cases, Gut, 37, 121, 10.1136/gut.37.1.121 Karimgani, 1992, Prognostic factors in sterile pancreatic necrosis, Gastroenterology, 103, 1636, 10.1016/0016-5085(92)91189-B Uomo, 1996, Non-surgical treatment of acute necrotizing pancreatitis, Pancreas, 12, 142, 10.1097/00006676-199603000-00006 De Boux, 1996, Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis, Br J Surg, 83, 349, 10.1002/bjs.1800830317 Buter, 2002, Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis, Br J Surg, 89, 298, 10.1046/j.0007-1323.2001.02025.x Lankisch, 1999, Acute pancreatitis: Which patient is most at risk?, Pancreas, 19, 321, 10.1097/00006676-199911000-00001 Bradley, 1992, A clinically based classification system for acute pancreatitis, Arch Surg, 128, 586, 10.1001/archsurg.1993.01420170122019 Bollaert, 1998, Reversal of late septic schock with supraphysiologic doses of hydrocortisone, Crit Care Med, 26, 645, 10.1097/00003246-199804000-00010 Briegel, 1999, Stress doses of hydrocortisone reverse hyperdynamic septic schock: A prospective, randomised, double-blind, single-center study, Crit Care Med, 27, 723, 10.1097/00003246-199904000-00025 Eisele, 1998, Antithrombin III in patients with severe sepsis: A randomised, placebo-controlled, double-blind, multicenter trial plus a meta-analysis on all randomised, placebo-controlled, douple-blind trials with antithrombin III in severe sepsis, Intensive Care Med, 24, 663, 10.1007/s001340050642 Bernard, 2001, Efficacy and safety of recombinant human activated protein C for severe sepsis, N Engl J Med, 344, 699, 10.1056/NEJM200103083441001 Uhl, 1996, Influence of etiology on the course and outcome of acute pancreatitis, Pancreas, 13, 335, 10.1097/00006676-199611000-00002